峆一药业
(430478)
| 流通市值：10.93亿 | | | 总市值：18.22亿 |
| 流通股本：4720.61万 | | | 总股本：7870.87万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 80,341,636.5 | 270,466,229.84 | 196,755,675.33 | 137,409,942.22 |
| 营业收入 | 80,341,636.5 | 270,466,229.84 | 196,755,675.33 | 137,409,942.22 |
| 二、营业总成本 | 60,975,738.28 | 219,747,298.5 | 159,583,009.37 | 107,412,546.17 |
| 营业成本 | 48,549,947.16 | 169,621,732.31 | 121,227,175.45 | 83,477,594.77 |
| 税金及附加 | 724,136.72 | 2,835,301.17 | 1,893,742.4 | 1,203,882.91 |
| 销售费用 | 903,567.34 | 2,008,623.53 | 1,331,995.81 | 1,122,606.61 |
| 管理费用 | 6,483,590.37 | 27,427,710.29 | 21,599,559.97 | 13,539,524.45 |
| 研发费用 | 4,785,242.61 | 20,513,979.77 | 15,384,389.34 | 9,691,309.95 |
| 财务费用 | -470,745.92 | -2,660,048.57 | -1,853,853.6 | -1,622,372.52 |
| 其中:利息费用 | - | 136,927.87 | 126,433.29 | 76,381.75 |
| 其中:利息收入 | - | 520,647.61 | 449,471.95 | 392,743.37 |
| 加:公允价值变动收益 | -823,286.14 | 460,620.39 | 602,001.38 | -132,915.3 |
| 加:投资收益 | 1,426,611.02 | 3,324,305.74 | 2,692,577.69 | 2,239,004.59 |
| 资产处置收益 | -11,502.28 | - | - | - |
| 资产减值损失(新) | - | -2,963,536.99 | - | - |
| 信用减值损失(新) | 409,452.54 | -539,661.07 | 186,874.8 | -236,161.66 |
| 其他收益 | 1,074,607.38 | 2,815,761.15 | 1,456,879.77 | 1,113,735.29 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 21,441,780.74 | 53,816,420.56 | 42,110,999.6 | 32,981,058.97 |
| 加:营业外收入 | 0.01 | 7,115.97 | 130,000 | 130,000 |
| 减:营业外支出 | 20,000 | 356,195.34 | 116,350.1 | 10,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 21,421,780.75 | 53,467,341.19 | 42,124,649.5 | 33,101,058.97 |
| 减:所得税费用 | 3,334,352.62 | 8,834,128.22 | 6,289,312.13 | 5,167,021.68 |
| 六、净利润 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 | 27,934,037.29 |
| 持续经营净利润 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 | 27,934,037.29 |
| 归属于母公司股东的净利润 | 19,231,299.51 | 49,664,051.16 | 37,401,751.95 | 29,125,262.12 |
| 少数股东损益 | -1,143,871.38 | -5,030,838.19 | -1,566,414.58 | -1,191,224.82 |
| (一)基本每股收益 | 0.34 | 0.89 | 0.67 | 0.52 |
| (二)稀释每股收益 | - | 0.89 | - | - |
| 九、综合收益总额 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 | 27,934,037.29 |
| 归属于母公司股东的综合收益总额 | 19,231,299.51 | 49,664,051.16 | 37,401,751.95 | 29,125,262.12 |
| 归属于少数股东的综合收益总额 | -1,143,871.38 | -5,030,838.19 | -1,566,414.58 | -1,191,224.82 |
| 公告日期 | 2025-04-28 | 2025-04-18 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |